FDA MAMMOGRAPHY QUALITY STANDARDS INTERIM REG
This article was originally published in The Gray Sheet
Executive SummaryFDA MAMMOGRAPHY QUALITY STANDARDS INTERIM REG seeks advice on standards that should be established for mammography of patients with breast implants. Published in the Dec. 21 Federal Register, the interim final reg explains that "FDA does not believe that sufficient information is presently available with regard to special requirements for mammography of patients with breast implants." The agency asks for "comments on standards for consideration in development of the final rule."
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Slovenia’s Krka has responded to media reports of “irregularities” at its Romanian subsidiary – including allegations of bribing local doctors to prescribe its products – by pledging to form a special investigation team to immediately examine the matter.